JP2017511321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017511321A5 JP2017511321A5 JP2016559887A JP2016559887A JP2017511321A5 JP 2017511321 A5 JP2017511321 A5 JP 2017511321A5 JP 2016559887 A JP2016559887 A JP 2016559887A JP 2016559887 A JP2016559887 A JP 2016559887A JP 2017511321 A5 JP2017511321 A5 JP 2017511321A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- formula
- alkyl
- independently
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCCCCCCCC(C(N1C(*)(*)[Al]*)=O)=CN2C1=NCC2 Chemical compound CCCCCCCCC(C(N1C(*)(*)[Al]*)=O)=CN2C1=NCC2 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461972689P | 2014-03-31 | 2014-03-31 | |
| US61/972,689 | 2014-03-31 | ||
| PCT/US2015/023362 WO2015153468A1 (en) | 2014-03-31 | 2015-03-30 | Pharmacophore for trail induction |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019164086A Division JP6873201B2 (ja) | 2014-03-31 | 2019-09-10 | Ｔｒａｉｌ誘導のためのファーマコフォア |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017511321A JP2017511321A (ja) | 2017-04-20 |
| JP2017511321A5 true JP2017511321A5 (enExample) | 2018-05-10 |
| JP6756435B2 JP6756435B2 (ja) | 2020-09-16 |
Family
ID=54241169
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016559887A Active JP6756435B2 (ja) | 2014-03-31 | 2015-03-30 | Ｔｒａｉｌ誘導のためのファーマコフォア |
| JP2019164086A Active JP6873201B2 (ja) | 2014-03-31 | 2019-09-10 | Ｔｒａｉｌ誘導のためのファーマコフォア |
| JP2021071035A Active JP7186256B2 (ja) | 2014-03-31 | 2021-04-20 | Ｔｒａｉｌ誘導のためのファーマコフォア |
| JP2022188821A Active JP7688245B2 (ja) | 2014-03-31 | 2022-11-28 | Ｔｒａｉｌ誘導のためのファーマコフォア |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019164086A Active JP6873201B2 (ja) | 2014-03-31 | 2019-09-10 | Ｔｒａｉｌ誘導のためのファーマコフォア |
| JP2021071035A Active JP7186256B2 (ja) | 2014-03-31 | 2021-04-20 | Ｔｒａｉｌ誘導のためのファーマコフォア |
| JP2022188821A Active JP7688245B2 (ja) | 2014-03-31 | 2022-11-28 | Ｔｒａｉｌ誘導のためのファーマコフォア |
Country Status (20)
| Country | Link |
|---|---|
| US (5) | US10239877B2 (enExample) |
| EP (3) | EP3662910B1 (enExample) |
| JP (4) | JP6756435B2 (enExample) |
| KR (2) | KR102611067B1 (enExample) |
| CN (2) | CN106456643B (enExample) |
| AU (4) | AU2015241069B2 (enExample) |
| CA (2) | CA3158795A1 (enExample) |
| CY (1) | CY1123093T1 (enExample) |
| DK (2) | DK3662910T3 (enExample) |
| ES (2) | ES2999685T3 (enExample) |
| FI (1) | FI3662910T3 (enExample) |
| HR (2) | HRP20200478T1 (enExample) |
| HU (2) | HUE049013T2 (enExample) |
| LT (2) | LT3125898T (enExample) |
| PL (2) | PL3662910T3 (enExample) |
| PT (2) | PT3125898T (enExample) |
| RS (2) | RS66254B1 (enExample) |
| SI (2) | SI3125898T1 (enExample) |
| SM (2) | SMT202400497T1 (enExample) |
| WO (1) | WO2015153468A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9688679B2 (en) | 2013-03-13 | 2017-06-27 | Oncoceutics, Inc. | 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy |
| US9265765B2 (en) | 2013-03-13 | 2016-02-23 | Oncoceutics, Inc. | 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy |
| US9376437B2 (en) | 2013-03-13 | 2016-06-28 | Oncoceutics, Inc | 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy |
| CN110669047A (zh) * | 2013-11-15 | 2020-01-10 | 昂克希尔迪克斯有限公司 | 用于治疗癌症的化合物、其组合物及应用方法 |
| RS66254B1 (sr) | 2014-03-31 | 2024-12-31 | Scripps Research Inst | Farmakofor koji indukuje trail |
| SI3805222T1 (sl) * | 2015-01-30 | 2025-04-30 | Oncoceutics, Inc. | Derivati 7-benzil-4-(2-metilbenzil)-2,4,6,7,8,9-heksahidroimidazo[1,2-a] pirido[3,4-e]pirimidin-5(1H)-ona, njihove soli in njihova uporaba v terapiji |
| CN104860948B (zh) * | 2015-05-15 | 2017-09-26 | 南京盖特医药技术有限公司 | 咪唑并嘧啶酮类化合物及其制备方法和应用 |
| CN115844895B (zh) * | 2016-01-29 | 2025-10-17 | 昂克希尔迪克斯有限公司 | 依米立酮化合物在制备用于治疗中枢神经系统癌症的药物中的用途 |
| US11091483B2 (en) | 2016-08-12 | 2021-08-17 | Madera Therapeutics, LLC | Protein kinase regulators |
| US10172862B2 (en) | 2017-01-30 | 2019-01-08 | Oncoceutics, Inc. | Imipridones for gliomas |
| GB2596010B (en) * | 2019-02-11 | 2023-03-01 | Madera Therapeutics Llc | Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents |
| CN113795251B (zh) | 2019-02-27 | 2026-01-13 | 马德拉治疗公司 | 酪蛋白水解蛋白酶p功能作为药物对imipridone样试剂响应的生物标志物的用途 |
| EP4192467A1 (en) | 2020-08-06 | 2023-06-14 | Eötvös Loránd Tudományegyetem | Synthesis of novel imipridone derivatives and their evaluation for their anticancer activity |
| CN115448921B (zh) * | 2021-06-08 | 2023-08-01 | 四川大学 | 一类咪唑烷并嘧啶酮化合物及在治疗HsClpP介导的疾病中的用途 |
| CN116751199B (zh) * | 2023-06-02 | 2025-03-18 | 中国科学院基础医学与肿瘤研究所(筹) | 一种线粒体蛋白酶靶向嵌合体、制备方法及用途 |
| EP4684834A1 (de) * | 2024-07-26 | 2026-01-28 | BRIU GmbH | Kristallformen onkologisch wirksamer imipridone und verfahren zu deren herstellung |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE786028A (fr) * | 1971-07-08 | 1973-01-08 | Boehringer Sohn Ingelheim | 2,3-dihydro-oxo-imidazo(1,2-a)-pyrimidines, leurs sels d'addition avec des acides et procedes pour les fabriquer |
| DE2150062A1 (de) | 1971-10-07 | 1973-04-12 | Boehringer Sohn Ingelheim | Imidazo- eckige klammer auf 1,2-a eckige klammer zu -pyrido- eckige klammer auf 4,3-d eckige klammer zu -pyrimidine, deren saeureadditionssalze und verfahren zu deren herstellung |
| JPS5374893A (en) | 1976-12-15 | 1978-07-03 | Fujitsu Ltd | Driving method for semiconductor photosensitive device |
| JPS6132833U (ja) | 1984-07-31 | 1986-02-27 | 日信工業株式会社 | デイスクブレ−キ装置 |
| JP2006506401A (ja) * | 2002-05-23 | 2006-02-23 | メルク エンド カムパニー インコーポレーテッド | 有糸分裂キネシン阻害薬 |
| DK2303264T3 (en) * | 2008-06-09 | 2018-05-22 | Allergan Inc | METHODS FOR TREATING ALPHA-ADRENERG-MEDIATED CONDITIONS USING IMIDAZOLINE DERIVATIVES |
| CA2795952A1 (en) * | 2010-04-16 | 2011-10-20 | Curis, Inc. | Treatment of cancers having k-ras mutations |
| US8691832B2 (en) * | 2010-12-06 | 2014-04-08 | Merck Sharp & Dohme Corp. | Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors |
| MX345400B (es) * | 2011-03-15 | 2017-01-30 | Chiesi Farm Spa | Derivados de isoxazolidina. |
| AU2012240246A1 (en) * | 2011-04-04 | 2013-05-09 | Netherlands Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
| HRP20200636T1 (hr) | 2011-04-29 | 2020-07-10 | The Penn State Research Foundation | Indukcija male molekule trail genoma u normalnim i tumorskim stanicama kao antikancerogena terapija |
| US9688679B2 (en) | 2013-03-13 | 2017-06-27 | Oncoceutics, Inc. | 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy |
| US9376437B2 (en) * | 2013-03-13 | 2016-06-28 | Oncoceutics, Inc | 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy |
| US9265765B2 (en) * | 2013-03-13 | 2016-02-23 | Oncoceutics, Inc. | 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy |
| WO2015073072A1 (en) * | 2013-11-15 | 2015-05-21 | Oncoceutics, Inc. | 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one |
| US9181237B2 (en) * | 2013-10-04 | 2015-11-10 | Mallinckrodt Llc | Substituted berbines and their synthesis |
| RS66254B1 (sr) | 2014-03-31 | 2024-12-31 | Scripps Research Inst | Farmakofor koji indukuje trail |
-
2015
- 2015-03-30 RS RS20241340A patent/RS66254B1/sr unknown
- 2015-03-30 EP EP19218049.5A patent/EP3662910B1/en active Active
- 2015-03-30 SM SM20240497T patent/SMT202400497T1/it unknown
- 2015-03-30 HU HUE15772254A patent/HUE049013T2/hu unknown
- 2015-03-30 CN CN201580021658.3A patent/CN106456643B/zh active Active
- 2015-03-30 LT LTEP15772254.7T patent/LT3125898T/lt unknown
- 2015-03-30 HR HRP20200478TT patent/HRP20200478T1/hr unknown
- 2015-03-30 EP EP24192819.1A patent/EP4470617A3/en active Pending
- 2015-03-30 PT PT157722547T patent/PT3125898T/pt unknown
- 2015-03-30 JP JP2016559887A patent/JP6756435B2/ja active Active
- 2015-03-30 CA CA3158795A patent/CA3158795A1/en active Pending
- 2015-03-30 LT LTEP19218049.5T patent/LT3662910T/lt unknown
- 2015-03-30 SI SI201531141T patent/SI3125898T1/sl unknown
- 2015-03-30 RS RS20200336A patent/RS60163B1/sr unknown
- 2015-03-30 PT PT192180495T patent/PT3662910T/pt unknown
- 2015-03-30 ES ES19218049T patent/ES2999685T3/es active Active
- 2015-03-30 WO PCT/US2015/023362 patent/WO2015153468A1/en not_active Ceased
- 2015-03-30 US US15/126,192 patent/US10239877B2/en active Active
- 2015-03-30 CN CN202010184181.3A patent/CN111499636B/zh active Active
- 2015-03-30 PL PL19218049.5T patent/PL3662910T3/pl unknown
- 2015-03-30 SI SI201532040T patent/SI3662910T1/sl unknown
- 2015-03-30 KR KR1020227042050A patent/KR102611067B1/ko active Active
- 2015-03-30 KR KR1020167029994A patent/KR102473930B1/ko active Active
- 2015-03-30 EP EP15772254.7A patent/EP3125898B1/en active Active
- 2015-03-30 DK DK19218049.5T patent/DK3662910T3/da active
- 2015-03-30 CA CA2944452A patent/CA2944452C/en active Active
- 2015-03-30 HR HRP20241680TT patent/HRP20241680T1/hr unknown
- 2015-03-30 PL PL15772254T patent/PL3125898T3/pl unknown
- 2015-03-30 ES ES15772254T patent/ES2779979T3/es active Active
- 2015-03-30 SM SM20200219T patent/SMT202000219T1/it unknown
- 2015-03-30 DK DK15772254.7T patent/DK3125898T3/da active
- 2015-03-30 HU HUE19218049A patent/HUE069651T2/hu unknown
- 2015-03-30 AU AU2015241069A patent/AU2015241069B2/en active Active
- 2015-03-30 FI FIEP19218049.5T patent/FI3662910T3/fi active
-
2019
- 2019-03-20 US US16/359,633 patent/US10633385B2/en active Active
- 2019-09-10 JP JP2019164086A patent/JP6873201B2/ja active Active
-
2020
- 2020-03-20 CY CY20201100267T patent/CY1123093T1/el unknown
- 2020-04-14 US US16/848,032 patent/US20200283440A1/en not_active Abandoned
- 2020-12-11 AU AU2020286314A patent/AU2020286314A1/en not_active Abandoned
-
2021
- 2021-04-20 JP JP2021071035A patent/JP7186256B2/ja active Active
- 2021-07-12 US US17/372,894 patent/US11891392B2/en active Active
-
2022
- 2022-11-28 JP JP2022188821A patent/JP7688245B2/ja active Active
- 2022-12-08 AU AU2022283729A patent/AU2022283729A1/en not_active Abandoned
-
2023
- 2023-12-20 US US18/391,420 patent/US20240190877A1/en active Pending
-
2024
- 2024-07-19 AU AU2024204977A patent/AU2024204977A1/en active Pending